Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
India
· Delayed Price · Currency is INR 1,145.00
-17.20 (-1.48%)
Mar 28, 2025, 3:30 PM IST
Dr. Reddy's Laboratories Employees
Dr. Reddy's Laboratories had 27,048 employees as of March 31, 2024. The number of employees increased by 1,185 or 4.58% compared to the previous year.
Employees
27,048
Change (1Y)
1,185
Growth (1Y)
4.58%
Revenue / Employee
11.51M INR
Profits / Employee
1.98M INR
Market Cap
953.17B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 9,741 |
| Cipla | 27,764 |
| Mankind Pharma | 19,540 |
| Apollo Hospitals Enterprise | 83,147 |
| Zydus Lifesciences | 26,921 |
| Aurobindo Pharma | 26,015 |
| Alkem Laboratories | 17,432 |
Dr. Reddy's Laboratories News
- 3 days ago - Bio-Thera and Dr. Reddy's Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, and BAT2506, a Proposed Simponi® Biosimilar, for Southeast Asia - PRNewsWire
- 4 days ago - Dr Reddy's inks pact with China’s Bio-Thera - The Times of India
- 4 days ago - Dr Reddy's inks South East Asia commercialisation, licence pacts with China's Bio-Thera for Stelara, Simponi biosimilars - The Times of India
- 6 days ago - Nifty 50 top losers today, March 25: IndusInd Bank, Dr. Reddy’s, Adani Enterprises, Coal India and more - Business Upturn
- 7 days ago - Pharma and hospital stocks in focus today: Alembic Pharma, Gland Pharma, Apollo Hospital, Fortis Healthcare, Dr Reddy’s [March 24, 2025] - Business Upturn
- 13 days ago - Alvotech and Dr. Reddy’s gets FDA nod for Biologic License Application for AVT03 - Seeking Alpha
- 13 days ago - Alvotech & Dr. Reddy’s receive FDA acceptance for AVT03, a proposed biosimilar to Prolia & Xgeva - Business Upturn
- 13 days ago - Alvotech and Dr. Reddy's Announce FDA Acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva® - Business Wire